<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Wed, 26 Aug 2026 18:36:04 -0400--><rss version="2.0">
    <channel>
        <title>Vivani Medical, Inc. (VANI) In the News</title>
        <link>https://investors.vivani.com/investors/news-events/in-the-news/rss</link>
        <description></description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_4126e3db6def33d543a652545d1b732f/vivanimedical/files/theme/images/logo-sm.png</url>
                <title>Vivani Medical, Inc. Logo</title>
                <link>/investors</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[CNBC published an in-depth interview of CEO Dr. Adam Mendelsohn conducted by Health and Science reporter Annika Kim Constantino on July 11, 2026.]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.cnbc.com/2026/07/11/glp-1-implant-from-vivani-medical-aims-to-help-patients-stay-on-treatment.html</link>
                <pubDate>Sat, 11 Jul 26 00:00:00 -0400</pubDate>
                <guid>https://www.cnbc.com/2026/07/11/glp-1-implant-from-vivani-medical-aims-to-help-patients-stay-on-treatment.html</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Biotech CEO on new Novo Nordisk partnership: “This could be big”]]></title>
                <description><![CDATA[]]></description>
                <link>https://medwatch.com/News/Pharma___Biotech/article19469168.ece</link>
                <pubDate>Fri, 10 Jul 26 00:00:00 -0400</pubDate>
                <guid>https://medwatch.com/News/Pharma___Biotech/article19469168.ece</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Novo Nordisk agrees to evaluate Vivani's semaglutide implant ahead of Phase I trial]]></title>
                <description><![CDATA[]]></description>
                <link>https://allsci.com/news/licensing-deals/novo-nordisk-agrees-to-evaluate-vivanis-semaglutide-implant-ahead-of-phase-i-trial/</link>
                <pubDate>Thu, 09 Jul 26 00:00:00 -0400</pubDate>
                <guid>https://allsci.com/news/licensing-deals/novo-nordisk-agrees-to-evaluate-vivanis-semaglutide-implant-ahead-of-phase-i-trial/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Healthcare Digital reported on the weight -management strategy of Novo Nordisk and Vivani Medical on July 8, 2026.  ]]></title>
                <description><![CDATA[]]></description>
                <link>https://healthcare-digital.com/news/novo-nordisk-vivani-medicals-weight-management-strategy</link>
                <pubDate>Wed, 08 Jul 26 00:00:00 -0400</pubDate>
                <guid>https://healthcare-digital.com/news/novo-nordisk-vivani-medicals-weight-management-strategy</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Work underway on new semaglutide implant—no needles or pills required]]></title>
                <description><![CDATA[]]></description>
                <link>https://cardiovascularbusiness.com/topics/clinical/heart-health/work-underway-new-semaglutide-implant-no-needles-or-pills-required</link>
                <pubDate>Wed, 08 Jul 26 00:00:00 -0400</pubDate>
                <guid>https://cardiovascularbusiness.com/topics/clinical/heart-health/work-underway-new-semaglutide-implant-no-needles-or-pills-required</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Vivani, Novo Nordisk partner to evaluate long-term semaglutide implant]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.drugdeliverybusiness.com/vivani-novo-nordisk-long-term-semaglutide-implant/</link>
                <pubDate>Tue, 07 Jul 26 00:00:00 -0400</pubDate>
                <guid>https://www.drugdeliverybusiness.com/vivani-novo-nordisk-long-term-semaglutide-implant/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Fierce Biotech reported on Novo Nordisk’s agreement to evaluate Vivani Medical’s NPM-139 (semaglutide implant) on July 7, 2026.]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.fiercebiotech.com/medtech/novo-nordisk-pens-glp-1-long-acting-implant-tech-deal-vivani-medical</link>
                <pubDate>Tue, 07 Jul 26 00:00:00 -0400</pubDate>
                <guid>https://www.fiercebiotech.com/medtech/novo-nordisk-pens-glp-1-long-acting-implant-tech-deal-vivani-medical</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[CEO Dr. Adam Mendelsohn joined Alejandro Cremades’ DealMakers Podcast 2024]]></title>
                <description><![CDATA[]]></description>
                <link>https://alejandrocremades.com/he-raised-100-million-to-develop-a-portfolio-of-miniature-long-term-implants-to-deliver-drugs-more-efficiently-and-consistently/</link>
                <pubDate>Tue, 17 Sep 24 00:00:00 -0400</pubDate>
                <guid>https://alejandrocremades.com/he-raised-100-million-to-develop-a-portfolio-of-miniature-long-term-implants-to-deliver-drugs-more-efficiently-and-consistently/</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[H.C. Wainwright 26th Annual Global Investment Conference]]></title>
                <description><![CDATA[]]></description>
                <link>https://journey.ct.events/view/a00c80c3-0668-4058-b4ca-4aad48978600</link>
                <pubDate>Wed, 11 Sep 24 00:00:00 -0400</pubDate>
                <guid>https://journey.ct.events/view/a00c80c3-0668-4058-b4ca-4aad48978600</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Vivani’s CEO Adam Mendelsohn Presenting at the Benzinga Virtual Healthcare Summit on March 20, 2024]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.linkedin.com/posts/vivani-medical_vivani-medical-adam-mendelsohn-benzinga-activity-7178137324071886848-zuVd?utm_source=share&amp;amp;utm_medium=member_desktop</link>
                <pubDate>Wed, 20 Mar 24 00:00:00 -0400</pubDate>
                <guid>https://www.linkedin.com/posts/vivani-medical_vivani-medical-adam-mendelsohn-benzinga-activity-7178137324071886848-zuVd?utm_source=share&amp;amp;utm_medium=member_desktop</guid>
                                                                            </item>
            </channel>
</rss>